Inconsistent with the results of previous studies, our findings suggest that PD leads to reduced levels of inflammatory factors such as MIG, bNGF, IL-17, IL-2, and IFNg through pathological pathways, which may be attributed to the fact that the levels of inflammatory markers are influenced by the course, extent, and duration of PD. The gene discussed is IFNG; the disease is Parkinson disease.